WO2005087758A1 - プロアントシアニジン水可溶性結合体およびそれを含有する組成物 - Google Patents
プロアントシアニジン水可溶性結合体およびそれを含有する組成物 Download PDFInfo
- Publication number
- WO2005087758A1 WO2005087758A1 PCT/JP2004/019793 JP2004019793W WO2005087758A1 WO 2005087758 A1 WO2005087758 A1 WO 2005087758A1 JP 2004019793 W JP2004019793 W JP 2004019793W WO 2005087758 A1 WO2005087758 A1 WO 2005087758A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water
- proanthocyanidin
- mass
- peptide
- proanthocyanidins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Definitions
- the present invention relates to a water-soluble conjugate that stabilizes proanthocyanidins and a composition containing the same.
- Proanthocyanidins are condensed tannins composed of polycondensates with flavan-13-ol and / or flavan-1,3 diol as structural units and a degree of polymerization of 2 or more, and have long been used to enhance skin astringency. It is used for the purpose of skin conditioning.
- proanthocyanidins have various activities such as an antioxidant effect and a whitening effect, they have been applied to foods, cosmetics and the like (Japanese Patent Application Laid-Open No. 61-16982). (Japanese Patent Publication No. JP-A-2-134309).
- it has been applied to cosmetics containing a protein (Japanese Patent Application Laid-Open Nos. 11-75708, 6-333642, and 2002-223). No. 8497).
- Proanthocyanidins are prone to oxidation due to their high antioxidant properties, causing autoacidic polymerization. This causes problems such as easy coloring. Furthermore, the degree of polymerization of proanthocyanidin is increased by autooxidation polymerization, so that its solubility in water is reduced and precipitation is liable to occur. Such proanthocyanidins having a high degree of polymerization cause a problem that the absorption efficiency in the body is reduced.
- Japanese Patent Application Laid-Open No. 2001-270708 discloses a method in which an amino acid having a hydroxyl group or a dipeptide containing the amino acid is added to proanthocyanidin. It is described that the discoloration of proanthocyanidin in solution is prevented by oxidative polymerization. However, these combinations cause precipitation when stored in the liquid state for long periods of time.
- proanthocyanidins cannot maintain their activity even when degraded by digestion processes in the body, and thus have a problem that absorption efficiency is deteriorated. Disclosure of the invention
- the present invention relates to a proanthocyanidin having a high protection stability and a retained or enhanced physiological activity, that is, a proanthocyanidin which does not precipitate even after long-term storage and can be transported into a living body while maintaining the physiological activity.
- the purpose is to provide.
- the present inventors have conducted intensive studies on the above-mentioned problems, and as a result, surprisingly, by binding a specific peptide to proanthocyanidin, precipitation does not occur even during long-term storage, and the bioactivity is excellent.
- the present inventors have found that a water-soluble conjugate of proanthocyanidin that can be transported into a living body while maintaining physiological activity is obtained, and the present invention has been accomplished.
- the water-soluble decades conjugate of the present invention comprises proanthocyanidin and a peptide containing three or more amino acids.
- the peptide has an average molecular weight of 7,000 or less.
- the proanthocyanidins are derived from plant extracts.
- composition of the present invention contains the above water-soluble conjugate.
- proanthocyanidins when proanthocyanidins, particularly plant extracts are used, proanthocyanidins in the plant extracts and peptides containing three or more amino acids
- the water-soluble conjugate has excellent protection stability of proanthocyanidins, has good absorbability, does not precipitate even during long-term storage, and has physiological activity derived from proanthocyanidins.
- the proanthocyanin in the water-soluble conjugate does not decompose during the digestion and absorption processes, so that the physiological activity is maintained in the body.
- the proanthocyanidins used in the water-soluble conjugate of the present invention are a group of compounds comprising a condensed polymer having flavan-3-ol and / or flavan-1,4-diol as a structural unit and having a degree of polymerization of 2 or more.
- Proanthocyanidins are a type of polyphenol and are powerful antioxidants produced by plants.
- the above-mentioned proanthocyanidins include pine, oak, saury, etc., grape, blueberry, strawberry, apogado, pseudocacia, lingonberry fruit or seed, barley, wheat, soybean, black soybean, cacao, red bean, Contained in conker shells, peanut skins and leaves of ginkgo. It is also found in cola nuts in West Africa, the roots of Ratania in Peru, and green tea in Japan.
- a condensation polymer having a low polymerization degree is preferable, a condensation polymer having a polymerization degree of 2 to 30 (2 to 30 mer) is preferable, and a polymerization degree of 2 to 1 is preferred.
- a polycondensate having 0 (2 to 10 mer) is more preferable, and a polycondensate having a polymerization degree of 2 to 4 (2 to 4 mer) is further preferable.
- the degree of polymerization is 2 to 4
- the polymer is referred to herein as OPC (oligomeric proanthocyanidin).
- OPC is a substance that cannot be produced in the human body.
- the conjugate consisting of OPC and peptide does not precipitate or suspend in solution, is stable in powder or solution, and the individual components It is preferable because it has a higher physiological activity than the effect.
- the proanthocyanin contains OPC.
- Proanthocyanidins of pentamer or more are susceptible to suspension or precipitation by binding to peptides, but when OPC is contained, suspension or precipitation due to aggregation of pentamer or more of proanthocyanidins is less likely to occur.
- the ratio of proanthocyanidins of pentamer or more to OPC is preferably at least 1 part by mass with respect to 1 part by mass of proanthocyanidin of at least pentamer.
- proanthocyanidins derived from the above plant extracts are particularly preferably used.
- OPC-rich plant extracts for example, 20 mass OPC. /.
- a plant extract containing preferably 30% by mass or more, more preferably 40% by mass or more is preferable.
- a pine bark extract is an example of a plant extract containing 20% by mass or more of OPC.
- proanthocyanidins are antioxidants, so they reduce the risk of adult diseases such as cancer, heart disease, cerebral thrombosis, etc., as well as arthritis-atopic dermatitis, hay fever, etc. It is known to have the effect of improving the allergic nature.
- OPC In addition to its antioxidant effects, OPC also reduces bacterial plaque by inhibiting bacterial growth in the oral cavity, restores the elasticity of blood vessels, Improves quality, enhances collagen, improves hyperlipidemia, prevents lipoproteins in the blood from being damaged by reactive oxygen, and aggregates damaged fat on the inner wall of blood vessels, causing cholesterol It is known to have an effect of preventing adhesion, an effect of regenerating vitamin E decomposed by active oxygen, an effect as an enhancer of vitamin E, and the like. Among them, blood flow can be improved by the effect of restoring elasticity of blood vessels. Furthermore, when collagen is used as a peptide, the skin quality can be improved by synergistic action with the strong effect.
- the plant extract When a plant extract containing proanthocyanidins is used, it is preferable that the plant extract further contains phytotechins. Preferably, the content is 5% by mass or more in the plant extract.
- the plant extract rich in proanthocyanin may contain catechins. Catechins are a generic term for polyhydroxyflapan-1-ol. As catechins, (+) Ichi-techin, (-1) -eppicatechin, (+)-gallocatechin, (-1) -epigallocatechin, Pigarocatechin galley, epicatechin gallate, etc. are known.
- gallocatechin, afzelechin, and (+)-catechin or 3-galloyl derivatives of gallocatechin have been isolated in addition to (+) one-pot techin, which is said to be catechin in a narrow sense.
- the catechins are preferably contained in the plant extract in an amount of 0.1 part by mass or more based on 1 part by mass of proanthocyanidin. More preferably, the starting plant extract containing 20% by mass or more of OPC contains 5% by mass or more of catechins. For example, when the catechin content of the pine bark extract is less than 5% by mass, the mass is 5 mass. A force techin may be added so as to be / 0 or more. It is most preferable to use a pine bark extract containing 5% by mass or more of phytotechins and 20% by mass or more of OPC.
- Catechins include carcinogenesis-suppressing action, arteriosclerosis-preventing action, fat metabolic disorder suppression action, blood pressure rise suppression action, platelet aggregation suppression action, antiallergic action, It is known to have a lubricating action, an antibacterial action, a caries preventing action, a bad breath preventing action, an intestinal bacterial flora normalizing action, a scavenging action of active individual oxygen and free radicals, and an antioxidant action. It is known that catechins have an antidiabetic effect of suppressing an increase in blood sugar. Catechins have the effect of making coagulation sedimentation and suspension of proanthocyanidin more difficult to occur.
- catechins have the property of activating OPC at the same time as increasing water solubility in the presence of OPC, and when taken together with OPC, enhance the action of OPC.
- Pine bark extracts include French pine (Pinus Martima), Japanese larch, Japanese black pine, Japanese pine, Japanese pine, Japanese pine, Japanese pine, Japanese pine, Japanese pine, Japanese pine, Japanese pine, Japanese white pine, Japanese pine, Aneda in Quebec, Canada.
- a bark extract of a plant belonging to the order Pinecaceae is preferably used. Above all, bark extract of French pine (Pinus Martima) is preferred.
- French pine is a marine pine that grows on part of the Atlantic coast of southern France. The bark of this French shore pine contains proanthocyanidins, organic acids, and other physiologically active ingredients, and its main ingredient, proanthocyanidins, has a strong antioxidant action that removes active oxygen. It is known.
- the pine bark extract is obtained by extracting the pine bark with water or an organic solvent.
- water it is preferable to use warm water or hot water. It is preferable to add a salt such as sodium chloride to these waters from the viewpoint of improving the extraction efficiency.
- organic solvent used for the extraction an organic solvent that is acceptable for the production of foods or pharmaceuticals is used.
- Xan-cyclohexane, Propylene Dali cone, Hydrous ethanol, Hydrous propylene dalicol, methyl ethyl ketone, glycerin, methyl acetate, ethyl acetate, getyl ether, dichloromethane, edible fat, 1,1,1,2-tetrafluoroethane, and 1,1,2-trichloroethene Are mentioned.
- These water and organic solvents may be used alone or in combination.
- water, hot water, ethanol, hydrous ethanol, and hydrous propylene glycol are preferable, and water, hot water, ethanol, and hydrous ethanol are more preferable from the viewpoint of safety when used in foods and pharmaceuticals.
- the method for extracting proanthocyanidins from pine bark is not particularly limited, but, for example, a heating extraction method, a supercritical fluid extraction method, or the like is used.
- Supercritical fluid extraction is a method in which a substance is extracted using a supercritical fluid, which is a fluid that has exceeded the critical point (critical temperature, critical pressure) of gas-liquid.
- a supercritical fluid which is a fluid that has exceeded the critical point (critical temperature, critical pressure) of gas-liquid.
- the supercritical fluid carbon dioxide, ethylene, propane, nitrous oxide (laughing gas) and the like are used, and dioxide carbon is preferably used.
- the supercritical fluid extraction method includes an extraction step of extracting a target component with a supercritical fluid, and a separation step of separating the target component from the supercritical fluid.
- a separation step either extraction separation by pressure change, extraction separation by temperature change, or extraction separation using an adsorbent / absorbent may be performed.
- supercritical fluid extraction by an entrainer addition method may be performed.
- ethanol, propanol, n-hexane, acetone, toluene, other aliphatic lower alcohols, aliphatic hydrocarbons, aromatic hydrocarbons, or ketones are added to a supercritical fluid.
- 2 Add about OW / V% and perform supercritical fluid extraction with the obtained extraction fluid to dramatically increase the solubility of the target extract such as OPC and catechins in the extraction solvent, or Is a method for enhancing the selectivity of separation and a method for efficiently obtaining a pine bark extract.
- Extraction from pine bark may be a combination of multiple extraction methods. Multiple extractions By combining the methods, pine bark extracts having various compositions can be obtained.
- the pine bark extract obtained by the above extraction may be purified for the purpose of increasing the content of proanthocyanidins.
- Solvents such as ethyl acetate are usually used for purification.
- water or ethanol is used, for example, ultrafiltration or synthetic adsorbent (Diaion HP- 20 or Sephadex-LH 20) is preferably purified by a column method or a patch method.
- the pine bark extract used as the plant extract of the present invention is specifically prepared by the following method, but this is only an example and the present invention is not limited to this method.
- a washing step of dissolving the precipitate in 10 mL of ethyl acetate and then adding the mixture to a 1-L form of chloroform to precipitate again is repeated twice.
- a pine bark extract containing not less than 20% by mass of OPC and not less than 5% by mass of force techins can be obtained. Extracts derived from raw material plants such as the pine bark described above are converted to OPC on a dry mass basis. And preferably 20 mass. / 0 or more, more preferably 30% by mass or more. Pine bark extract is preferably used as a raw material containing a high proportion of OPC.
- the extract extracted from plants using water or ethanol as described above also contains pentamer or more proanthocyanidins.However, based on the solubility of proanthocyanidins in polar solvents, Most are less than 10 to 20 mer.
- the peptide used in the present invention may contain at least three amino acids, and is not particularly limited to the types of amino acids and their combinations.
- the peptide may be an animal or plant-derived protein and its degradation product, or may be a peptide obtained by organic synthesis.
- animal- or plant-derived proteins and their degradation products examples include animal proteins derived from livestock meat, fish, animal milk, eggs, etc., such as cows, pigs, and chickens; soybeans, carrots, wheat, corn, and pea. Vegetable proteins derived from peas and the like; and degradation products thereof.
- peptides derived from soybean, collagen, and carrot are preferable, and soybean decomposed products, collagen peptide, and peptide derived from carrot are most preferable.
- the protein may be used as a raw material as it is, or may be used as an extract using a solvent such as water or an organic solvent.
- the degradation product of the protein can be obtained by decomposing the ground or extract of the animal or plant protein using an acid, an alkali, or an enzyme.
- Collagen is a major protein that makes up the connective tissue of animals, and is abundant in bones, tendons, skin, blood vessel walls, and so on. There are various types with one or more triple helix structures in the molecule and different amino acid sequences of the constituent polypeptide chains.
- Gelatin which is a denatured form of collagen, heats raw materials containing collagen
- the collagen peptide is obtained by decomposing the collagen or gelatin, for example, as follows. First, the skin or bone of cattle, pigs, etc. is subjected to acid treatment by immersing it in an alkaline solution for 2 to 3 months or acid treatment by immersing it in dilute hydrochloric acid for a short period of time to remove impurities contained in the raw materials. Perform pre-processing to facilitate extraction. For example, if the raw material is beef bone, the bone contains minerals such as calcium phosphate, so that the bones are pre-soaked in dilute hydrochloric acid to remove the minerals and then extracted with warm (hot) water to obtain gelatin. You.
- Hot (hot) water extraction generally involves an initial extraction temperature of 50-60 ° C, a subsequent increase of the extraction temperature, and boiling.
- the obtained gelatin is hydrolyzed with a commonly used acid or enzyme.
- a collagen peptide is obtained.
- Such collagen peptides are commercially available and readily available.
- Futtsu Peptide PBF, Futtsu Peptide PR A both made by Futtsu Co., Ltd.
- SCP-5000, SCP-3100 all made by Nitta Gelatin Co., Ltd.
- Collagen Peptide DS Kerowa High Foods
- Falconix CTP Ichimaru Falcos Co., Ltd.
- the soybean fraction is obtained by, for example, hydrolyzing an isolated soybean protein obtained by defatting soybean and acid-precipitating soymilk extracted with water, using an alkali, a decomposition treatment using an acid, an enzyme, an oxidizing agent or a reducing agent, or It is obtained by decomposing with these combinations and fractionating peptides having a constant molecular weight as necessary, and commercially available products can be easily obtained.
- the carrot-derived peptide preferably has a similar amino acid composition to animal collagen.
- a peptide derived from Daucus carota L. is a collagen-like peptide.
- the average molecular weight of a peptide containing three or more of these amino acids is not particularly limited.
- the average molecular weight is 7,000 or less, more preferably, the average molecular weight is 400 to 7,000, further preferably, 400 to 6,500, particularly preferably 400 to 3, , 0 0 0.
- the average molecular weight is larger than 7,000, it binds to many proanthocyanidins and forms large conjugates, which may cause precipitation or suspension. Absorption may be hindered.
- Peptides having an average molecular weight of less than 400 may cause cohesive precipitation upon long-term storage. (Water-soluble conjugate)
- the water-soluble conjugate of the present invention comprises proanthocyanidin, particularly when a plant extract is used, proanthocyanidin in the plant extract and a peptide containing three or more amino acids.
- the ratio of proanthocyanidins to the peptide containing three or more amino acids is not particularly limited. From the viewpoint of the protective stability of proanthocyanidin in the water-soluble conjugate, 1 part by mass of proanthocyanidin and 1 or more parts by mass of a peptide containing three or more amino acids, for example, a peptide derived from soybean or collagen, More preferably, it is 5 parts by mass or more, further preferably 5 parts by mass to 300 parts by mass, and most preferably 5 parts by mass to 150 parts by mass. If the amount is less than 1 part by mass, the protective stability of proanthocyanidin may not be sufficient.
- the water-soluble conjugate of the present invention is a polar solvent such as water and ethanol.
- a polar solvent such as water and ethanol.
- proanthocyanidins especially plant extracts
- the polar solvent is preferably water.
- mixing is performed by mixing a proanthocyanidin-containing solution in which a dry powder of proanthocyanin is dissolved in a polar solvent and a peptide-containing solution in which a peptide containing three or more amino acids is dissolved in the same polar solvent.
- the mixing ratio is not particularly limited.
- the proanthocyanidin-containing solution is preferably 1/50 volume part or more, more preferably 1 to 1 volume part, per 1 volume part of the peptide-containing solution. 0 capacity part or more.
- the polar solvent When the polar solvent is added after mixing the dry powder of proanthocyanidin and the dry powder of peptide, it is possible to atomize the polar solvent while stirring the mixed powder to form a uniform water-soluble conjugate. It is preferable from the point of obtaining.
- the obtained water-soluble conjugate may then be powdered by a processing method usually used by those skilled in the art. Powdering is performed by, for example, spraying a polar solvent while stirring a mixed powder of an anthocyanidin and a peptide using a fluidized bed granulator or the like. Liquid water-soluble, even when powdered It has an effect similar to that of the conjugate. For example, proanthocyanin has little deterioration such as discoloration, retains or enhances its physiological activity, and can exert its activity in vivo.
- the water-soluble conjugate of the present invention provides a proanthocyanin by binding a peptide containing three or more amino acids to proanthocyanin, particularly when a plant extract is used, to proanthocyanidin in the plant extract.
- the protective stability of nisin is enhanced, and the biological activity is maintained or enhanced. Therefore, no precipitation occurs even when stored in a liquid state for a long period of time, and it can be transported into a living body while maintaining the physiological activity.
- the water-soluble conjugate of the present invention is used as foods, pharmaceuticals, quasi-drugs, cosmetics, toiletries, etc., and exerts its effects when used for oral administration and transdermal administration. obtain. In particular, it is suitable to be used as an oxidation stabilizer for liquid products. (Water-soluble conjugate-containing composition)
- the composition of the present invention contains the above water-soluble conjugate, and may contain other components as necessary. This composition is used as foods, pharmaceuticals, quasi-drugs, cosmetics, toiletries and the like, like the water-soluble conjugate.
- the amount of the water-soluble conjugate contained in the fibrous composition of the present invention varies depending on the administration method and dosage form, and is not particularly limited.
- the yarn was 0 Puroantoshia two gin on a dry weight basis. 0 0 0 0 1% to 5 0 mass 0/0, more preferably 0. 0 0 1% to 4 0% by weight More preferably, it is contained so as to be 0.01% by mass to 20% by mass.
- composition of the present invention contains, in addition to the water-soluble conjugate, other components commonly used in pharmaceuticals, foods, quasi-drugs, cosmetics, and the like as long as the effects of the composition are not impaired. May be.
- Such components include, for example, water, medicinal ingredients, Examples include antioxidants, other oils, humectants, surfactants, ultraviolet absorbers, absorption enhancers, fragrances, dyes, preservatives, thickeners, chelating agents, preservatives and fungicides.
- Pharmaceutical ingredients include active oxygen scavengers, antioxidants, anti-inflammatory analgesics, antihistamines, antipruritics, bactericides, vitamins, hormones, and the like.
- An antioxidant is added for the purpose of further increasing the stability of proanthocyanidin to oxidation. In addition, it also has the effect of preventing oxidation of proteins and lipids in the body, improving and protecting skin quality.
- Antioxidants include carotenoids such as vitamin A, vitamins B, ascorbic acid, vitamin E, derivatives or salts thereof, L-cysteine and derivatives and salts thereof, riboflavin, SOD, mannitol , Tryptophan, histidine, quercetin, gallic acid and its derivatives, tea extracts, and daltathione yeast extracts. Preferred are ascorbic acid and derivatives and salts thereof.
- Ascorbic acid or a derivative thereof or a salt thereof not only enhances the stability of proanthocyanidins but also synergistically exerts an effect on skin and lipid metabolism, thereby improving skin quality. (For example, the effect of improving sharpness) and enhance the vascular protection effect.
- Ascorbic acid and the like may be contained in an amount of preferably from 0.1 to 50 parts by mass, more preferably from 0.2 to 20 parts by mass, per 1 part by mass of proanthocyanidin.
- composition of the present invention When the composition of the present invention is used for oral administration of foods and the like, if necessary, excipients, extenders, binders, thickeners, emulsifiers, coloring agents, flavors, food additives, etc. It can be mixed with additives such as seasonings.
- Food additives as nutritional components such as royal jelly, vitamins, proteins, calcium such as eggshell calcium, chitosan, lecithin, chlorella powder, ashitapa powder, moloheiya powder, etc .; stevia powder, matcha powder, lemon powder, honey, reduced malt Seasonings such as sugar, lactose, and sugar solutions may be mixed.
- Capsules such as soft capsules and soft capsules, anchors or pills, or powder, granules, tea, tea bags, candy, liquid, paste and the like. These may be eaten or consumed as they are, or may be dissolved in water, hot water, milk or the like, depending on the shape or taste.
- the composition of the present invention can be used as a drug, a quasi-drug, a cosmetic, and a toiletry article for transdermal administration.
- local long-term administration can be performed by a method such as holding and absorbing in a carrier such as a ship or a gel or a cross-linking agent, and applying the composition to a topical part.
- the daily dose of the composition of the present invention when ingested by oral administration is not particularly limited, but is preferably in the range of 0.02 g to lg as proanthocyanidin. Activity can be obtained. Further, in the case of transdermal administration, since the administration is topical, it is possible to obtain a physiological activity if it is prepared to have the above-mentioned constant concentration.
- the antioxidant power in blood and the improvement of blood flow are superior when a substance of the present invention is taken in an appropriate amount, compared to when a proanthocyanin and a peptide containing three or more amino acids are taken alone. Effects and skin quality improvement effects. Particularly excellent effects are obtained when a plant extract containing 20% by mass or more of OPC in terms of dry mass is used.
- TLC silica gel chromatography
- TLC Seri force gel plate (Merck & Co., Inc.)
- Example 1 Except for using the aqueous solution containing 0.1% by mass of the pine bark extract of Example 1 in place of the mixture, the presence or absence of formation of a conjugate was confirmed by TLC in the same manner as in Example 1. (Comparative Example 1).
- the soybean decomposition product of Example 1 (Comparative Example 2) containing 2% by mass (average molecular weight of about 400) and 2% by mass of glycine (molecular weight: 75, manufactured by Wako Pure Chemical Industries, Ltd.)
- pine bark extract A 20 g of the pine bark extract (hereinafter referred to as pine bark extract A) used in Example 1 was separated by separation on Sephadex LH-20 (manufactured by Furimasia Paiotech Co., Ltd.), and the dry powder mass was measured. At 7.6 g of dimer to tetramer, 5.1 g of pentamer or more proanthocyanidins were recovered. Separation by Sephadex LH-20 was performed twice under the following conditions.
- TLC silica gel chromatography
- the obtained pentamer or more proanthocyanidin 0.1 lg was mixed with the above pine bark extract A powder 1 g, and 36% by mass of dimer to tetramer (OPC) and pentamer were mixed.
- a pine bark extract containing 31% by mass of the above proanthocyanidins was prepared (hereinafter referred to as pine bark extract B).
- the pine husk extract B obtained above was adjusted to a final concentration of 0.2% by mass. It was dissolved in an aqueous solution (this is referred to as proanthocyanidin-containing solution 1). Separately, the OPC fraction of the pine bark extract A was referred to as a proanthocyanidin-containing solution 2, and the pentamer or higher pentose anthocyanidin fraction was referred to as a proanthocyanidin-containing solution 3.
- Collagen (average molecular weight 300,000: manufactured by Koken Co., Ltd.), Futsubutide PA-100 (average molecular weight 10,000: manufactured by Futtsu Co., Ltd.), collagen peptide DS (average molecular weight 7,000: manufactured by Kyowa High Foods Co., Ltd.) , SCP-5000 (average molecular weight 5,000: manufactured by Nitta Gelatin Co., Ltd.), Falconix
- CTP average molecular weight: 3,000: manufactured by Ichimaru Fuarcos Co., Ltd.
- -PP Tide PA-10 average molecular weight: 1,000: manufactured by Futtsubi Corporation
- soybean decomposed product average molecular weight: about 400, high yield
- PM Fuji Oil Co., Ltd.
- serine monoglutamic acid dipeptide Sigma Aldrich Japan
- glycine molecular weight: 75, manufactured by Wako Pure Chemical Industries, Ltd.
- proanthocyanidin proanthocyanin-containing solution 2
- proanthocyanidin containing OPC proanthocyanidin
- a solution containing the proanthocyanidin and a peptide containing an amino acid (glycine) and two or less amino acids (a serine-glutamic acid dipeptide) can be used.
- Precipitation / suspension was observed in the mixture with water alone (control 1) or ascolevic acid (control 2).
- collagen having an average molecular weight of 300,000 was used, gelled solids were precipitated.
- the water-soluble conjugate shows excellent storage stability, It is clear that turbidity does not easily occur.
- This mixed solution was orally administered to rats of each group using a sonde so that the contained pine bark extract was 100 mg / kg body weight.
- a group to which purified water was administered was provided.
- blood was collected again from the fundus and SOD activity was measured. Table 4 shows the results. Table 4
- test solution 1 (containing food 1 using pine bark extract and soybean decomposed product) was converted to test solution 2 (food using pine bark extract and soy protein).
- Test liquid 3 (contains food 3 using pine bark extract and dipeptide of serine monoglutamic acid), test liquid 4 (contains food 4 using only pine bark extract), or purified water (contains) It shows that the SOD activity in the blood is higher than that of non-food.
- the antioxidant activity which is one of the physiological activities of proanthocyanidin, was at least protected from the digestive process and absorbed, and the in vivo SOD activity by broantocyanidin was enhanced. Is shown.
- the SOD activity 45 minutes after ingestion was particularly low, so it is considered that absorption was inhibited.
- Soy beptide (average molecular weight 700) 0.1% by mass Pine bark extract 0.02% by mass Sodium ascorbate 0.016% by mass Fructose 0.3% by mass Orange juice 1.0% water
- An external preparation (lotion) was prepared in the following amount.
- This lotion when applied, was a stable external preparation with excellent epidermal blood flow improving effect and moisturizing properties, and no sedimentation:
- Collagen peptide (average molecular weight 1, 0 0 0) 0. 0 0 5 wt% pine bark extract. 0 5 wt% E Chino Rare Roh record Honoré 2 0 mass 0/0
- the water-soluble conjugate of the present invention comprises proanthocyanidin and a peptide containing three or more amino acids.
- the protection stability of proanthocyanidin is enhanced, and the biological activity is maintained or enhanced. Therefore, no precipitation occurs even when stored in a liquid state for a long period of time, and it can be transported into a living body while maintaining the physiological activity.
- the water-soluble conjugate of the present invention is used as foods, pharmaceuticals, quasi-drugs, cosmetics, toiletries and the like, and is used for any of oral administration and transdermal administration. In particular, it can be used as an oxidation stabilizer for liquid products.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Mycology (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002558975A CA2558975A1 (en) | 2004-03-15 | 2004-12-24 | Water-soluble bound matter of proanthocyanidin and composition containing the same |
US10/598,858 US20070184126A1 (en) | 2004-03-15 | 2004-12-24 | Water-soluble bound matter of proanthocyandin and composition containing the same |
JP2006510880A JP4648309B2 (ja) | 2004-03-15 | 2004-12-24 | プロアントシアニジン水可溶性結合体およびそれを含有する組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-072382 | 2004-03-15 | ||
JP2004072382 | 2004-03-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005087758A1 true WO2005087758A1 (ja) | 2005-09-22 |
Family
ID=34975513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/019793 WO2005087758A1 (ja) | 2004-03-15 | 2004-12-24 | プロアントシアニジン水可溶性結合体およびそれを含有する組成物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20070184126A1 (ja) |
JP (1) | JP4648309B2 (ja) |
KR (1) | KR20060130739A (ja) |
CA (1) | CA2558975A1 (ja) |
WO (1) | WO2005087758A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100817876B1 (ko) * | 2006-04-18 | 2008-03-31 | 전북대학교산학협력단 | 소나무 수피로부터 프로안토시아니딘의 분리방법 |
JP2009189276A (ja) * | 2008-02-13 | 2009-08-27 | Rohto Pharmaceut Co Ltd | ダイズペプチド含有液状食品 |
JP2010537976A (ja) * | 2007-09-04 | 2010-12-09 | コッテ,リミテッド | ビタミンcを含む化粧品組成物 |
JP2011051967A (ja) * | 2009-08-03 | 2011-03-17 | Fancl Corp | コラーゲンゲル収縮剤 |
JP2011201819A (ja) * | 2010-03-26 | 2011-10-13 | Toyo Shinyaku Co Ltd | 血漿ホモシステイン濃度上昇抑制用組成物および高ホモシステイン血症予防または改善用組成物 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113712957A (zh) * | 2021-08-19 | 2021-11-30 | 温州医科大学附属眼视光医院 | 一种低聚原花青素的眼用产品制备方法及应用 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000060482A (ja) * | 1998-06-11 | 2000-02-29 | Fancl Corp | 食品組成物 |
JP2002238497A (ja) * | 2001-02-19 | 2002-08-27 | Fancl Corp | 食品組成物 |
WO2002089758A1 (de) * | 2001-05-10 | 2002-11-14 | Cognis France S.A. | Verwendung von oligomeren procyanolidinen |
JP2003176219A (ja) * | 2001-12-13 | 2003-06-24 | Ichimaru Pharcos Co Ltd | コラーゲントリペプチド含有皮膚外用剤 |
JP2003183129A (ja) * | 2001-12-20 | 2003-07-03 | Nonogawa Shoji Kk | メイクアップ化粧料 |
JP2004123637A (ja) * | 2002-10-04 | 2004-04-22 | Ichimaru Pharcos Co Ltd | ヒアルロン酸産生促進剤 |
JP2004123630A (ja) * | 2002-10-03 | 2004-04-22 | Chisso Corp | 抗う蝕、抗歯周病性組成物 |
JP2004196756A (ja) * | 2002-12-13 | 2004-07-15 | Lion Corp | 口腔用組成物 |
JP2004290102A (ja) * | 2003-03-27 | 2004-10-21 | Toyo Shinyaku:Kk | 食品組成物 |
JP2004292378A (ja) * | 2003-03-27 | 2004-10-21 | Toyo Shinyaku:Kk | 皮膚外用剤 |
JP2004331609A (ja) * | 2003-05-09 | 2004-11-25 | Chisso Corp | 毛髪化粧料組成物 |
JP2004346132A (ja) * | 2003-05-20 | 2004-12-09 | Toyo Shinyaku:Kk | フラバン化合物含有組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6116982A (ja) * | 1984-07-03 | 1986-01-24 | Kikkoman Corp | 抗酸化剤 |
JP3547981B2 (ja) * | 1997-07-15 | 2004-07-28 | キッコーマン株式会社 | 蛋白食品 |
BRPI0003166B1 (pt) * | 1999-07-16 | 2015-08-25 | Natura Cosmeticos Sa | Processo para estabilização de compostos antioxidantes, e composições aquosas |
JP3616286B2 (ja) * | 1999-08-12 | 2005-02-02 | キッコーマン株式会社 | プロアントシアニジンの渋味低減方法 |
JP4574788B2 (ja) * | 2000-03-24 | 2010-11-04 | 協和発酵バイオ株式会社 | プロアントシアニジン含有組成物 |
-
2004
- 2004-12-24 US US10/598,858 patent/US20070184126A1/en not_active Abandoned
- 2004-12-24 KR KR1020067021377A patent/KR20060130739A/ko not_active Application Discontinuation
- 2004-12-24 CA CA002558975A patent/CA2558975A1/en not_active Abandoned
- 2004-12-24 JP JP2006510880A patent/JP4648309B2/ja active Active
- 2004-12-24 WO PCT/JP2004/019793 patent/WO2005087758A1/ja active Application Filing
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000060482A (ja) * | 1998-06-11 | 2000-02-29 | Fancl Corp | 食品組成物 |
JP2002238497A (ja) * | 2001-02-19 | 2002-08-27 | Fancl Corp | 食品組成物 |
WO2002089758A1 (de) * | 2001-05-10 | 2002-11-14 | Cognis France S.A. | Verwendung von oligomeren procyanolidinen |
JP2003176219A (ja) * | 2001-12-13 | 2003-06-24 | Ichimaru Pharcos Co Ltd | コラーゲントリペプチド含有皮膚外用剤 |
JP2003183129A (ja) * | 2001-12-20 | 2003-07-03 | Nonogawa Shoji Kk | メイクアップ化粧料 |
JP2004123630A (ja) * | 2002-10-03 | 2004-04-22 | Chisso Corp | 抗う蝕、抗歯周病性組成物 |
JP2004123637A (ja) * | 2002-10-04 | 2004-04-22 | Ichimaru Pharcos Co Ltd | ヒアルロン酸産生促進剤 |
JP2004196756A (ja) * | 2002-12-13 | 2004-07-15 | Lion Corp | 口腔用組成物 |
JP2004290102A (ja) * | 2003-03-27 | 2004-10-21 | Toyo Shinyaku:Kk | 食品組成物 |
JP2004292378A (ja) * | 2003-03-27 | 2004-10-21 | Toyo Shinyaku:Kk | 皮膚外用剤 |
JP2004331609A (ja) * | 2003-05-09 | 2004-11-25 | Chisso Corp | 毛髪化粧料組成物 |
JP2004346132A (ja) * | 2003-05-20 | 2004-12-09 | Toyo Shinyaku:Kk | フラバン化合物含有組成物 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100817876B1 (ko) * | 2006-04-18 | 2008-03-31 | 전북대학교산학협력단 | 소나무 수피로부터 프로안토시아니딘의 분리방법 |
JP2010537976A (ja) * | 2007-09-04 | 2010-12-09 | コッテ,リミテッド | ビタミンcを含む化粧品組成物 |
JP2009189276A (ja) * | 2008-02-13 | 2009-08-27 | Rohto Pharmaceut Co Ltd | ダイズペプチド含有液状食品 |
JP2011051967A (ja) * | 2009-08-03 | 2011-03-17 | Fancl Corp | コラーゲンゲル収縮剤 |
JP2011201819A (ja) * | 2010-03-26 | 2011-10-13 | Toyo Shinyaku Co Ltd | 血漿ホモシステイン濃度上昇抑制用組成物および高ホモシステイン血症予防または改善用組成物 |
Also Published As
Publication number | Publication date |
---|---|
JP4648309B2 (ja) | 2011-03-09 |
KR20060130739A (ko) | 2006-12-19 |
JPWO2005087758A1 (ja) | 2008-01-24 |
US20070184126A1 (en) | 2007-08-09 |
CA2558975A1 (en) | 2005-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006046557A1 (ja) | 異常蛋白質除去用組成物 | |
JP2006298857A (ja) | 育毛剤および育毛用キット | |
JP2005029486A (ja) | 皮膚改善組成物 | |
JP2003325135A (ja) | 健康食品 | |
JP2006016390A (ja) | プロアントシアニジン含有組成物 | |
JP2004123707A (ja) | 血流改善組成物 | |
WO2004080994A1 (ja) | プロアントシアニジン高含有物の製造方法 | |
JP3556659B1 (ja) | 食品組成物 | |
JP2005097273A (ja) | 運動能力向上組成物 | |
JP2010159283A (ja) | プロアントシアニジン含有組成物 | |
JP3689413B2 (ja) | フラバン化合物含有組成物 | |
JP4648309B2 (ja) | プロアントシアニジン水可溶性結合体およびそれを含有する組成物 | |
JP3533392B1 (ja) | 皮膚外用剤 | |
JP2004049135A (ja) | 健康食品 | |
JP2003146899A (ja) | 皮膚改善剤 | |
JP2003334022A (ja) | 持久力向上用食品組成物 | |
JP2003325136A (ja) | 関節炎改善用食品 | |
JP2005047839A (ja) | プロアントシアニジン含有組成物 | |
JP2005060338A (ja) | プロアントシアニジン含有組成物 | |
JP2003095965A (ja) | 高血圧症の予防・治療剤 | |
JP5681895B2 (ja) | 食品組成物 | |
US7939623B2 (en) | Composition containing flavan compound | |
JP2003238426A (ja) | コラゲナーゼ阻害剤、皮膚外用剤および健康食品 | |
JP2004210675A (ja) | 骨量改善組成物 | |
US20060134179A1 (en) | Health food product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006510880 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2558975 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10598858 Country of ref document: US Ref document number: 2007184126 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067021377 Country of ref document: KR |
|
122 | Ep: pct application non-entry in european phase | ||
WWP | Wipo information: published in national office |
Ref document number: 10598858 Country of ref document: US |